Sgk, a putative serine/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans

J Am Soc Nephrol. 1999 Dec;10(12):2488-94. doi: 10.1681/ASN.V10122488.

Abstract

Differential display PCR was used to identify alternate expression of serum glucocorticoid-regulated kinase (Sgk) mRNA in diabetes-induced renal disease. Differential expression of Sgk mRNA was identified in the kidneys of normal and obese db/db mice, a model of select aspects of human diabetic nephropathy. Sgk mRNA was selectively increased in diabetic mouse kidneys. The Sgk mRNA levels remained constant in other tissues from obese db/db mice. An increase in Sgk mRNA was also observed in the human diabetic kidney. In addition, thrombin, which may play a role in the progression of renal disease, increased Sgk message in cell culture. Because the diabetes-induced increase in Sgk was only observed in the kidney, which is particularly susceptible to diabetes-induced damage, Sgk may play a role in diabetic nephropathy.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Base Sequence
  • Cells, Cultured
  • DNA Primers / genetics
  • Diabetic Nephropathies / enzymology*
  • Diabetic Nephropathies / genetics*
  • Gene Expression / drug effects
  • Humans
  • Immediate-Early Proteins
  • Kidney / enzymology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Nuclear Proteins*
  • Polymerase Chain Reaction
  • Protein Serine-Threonine Kinases / genetics*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Species Specificity
  • Thrombin / pharmacology
  • Tissue Distribution

Substances

  • DNA Primers
  • Immediate-Early Proteins
  • Nuclear Proteins
  • RNA, Messenger
  • Protein Serine-Threonine Kinases
  • serum-glucocorticoid regulated kinase
  • Thrombin